Business

Sun Pharma And Aurobindo Recall Medications From US Markets

The US Food & Drug Administration reports that major pharmaceutical companies Sun Pharmaceutical Industries and Aurobindo Pharma are recalling items from the US market because of production problems.

According to the most recent Enforcement Report issued by the American health agency, Sun Pharma’s US-based business is recalling 69,707 cartons of Cequa (cyclosporine ophthalmic solution) from the US market.

The medicine is prescribed to treat dry eyes.

USFDA reported, “New Jersey-based Sun Pharmaceutical Industries Inc is recalling the product for being Subpotent”.

On September 7, this year, the business began a countrywide (US) Class III recall.

A Class III recall is issued when the use of, or exposure to, a violative product is not likely to cause adverse health consequences, according to the USFDA.

According to the US Food and Drug Administration, Aurobindo Pharma is recalling 9,890 bottles of Rasagiline Tablets, a drug used to treat Parkinson’s disease, from the United States.

“New Jersey-based Aurobindo Pharma USA Inc, a unit of the Hyderabad-based drug major, is recalling the affected lot due to Failed dissolution specifications”, the USFDA continued.

On August 2, this year, the business began the Class II recall in the United States.

With a current market size of over $50 billion, India’s pharmaceutical business is the third largest in the world by volume.

In 2021-22, India exported medicines worth Rs. 1,75,040 crore, comprising bulk medications and drug intermediates.

Also read: Air India Cancels Flights To Tel Aviv, Israel, Until October 14

Spriha Rai

Recent Posts

‘In Kabul, A Cat Has More Freedom Than A Woman’: Revisiting Women’s Struggles Under The Taliban

The Taliban’s regime has since imposed over 100 laws restricting women's rights, stripping them of…

4 hours ago

PM Modi’s Gifts: A Glimpse Of India’s Cultural Heritage In Global Diplomacy

These gifts to world leaders reflect the diverse traditions, arts, and crafts of India, emphasizing…

7 hours ago

Dr Rajeshwar Singh Calls For Bold Goals To Make India A Global Power By 2047

Dr Singh stressed the importance of reaching a GDP of $15 trillion by 2047 to…

7 hours ago

Gautam Adani Faces Indictment In US: Legal Expert Vijay Aggarwal Dismisses Immediate Repercussions

Criminal lawyer Vijay Aggarwal weighed in on the charges against Adani. He believes the indictment…

7 hours ago

Adani Group Stocks Recover As Sensex nd Nifty Post Gains

After a major sell-off earlier in the week, Adani Group stocks, led by Ambuja Cements…

9 hours ago

Sensex Soars 1,961 Points, Nifty Gains 557 In Broad-Based Market Rally

A sharp rally in financial stocks and encouraging US labor market data fueled the uptrend.…

9 hours ago